Strides Pharma Science LtdPharmaceuticalsINE939A01011Consolidated₹1219.80+19.60 (+1.63%)Jun-26
Valuation
Market Cap₹11.24K Cr
TTM PE18.33x
Forward PE17.35x
PEG1.78
Book Value₹337.15
P/B3.62x
TTM EPS₹66.56
Fwd EPS₹70.29
TTM Revenue₹5.00K Cr
TTM PAT₹634.41 Cr
TTM EBITDA₹937.01 Cr
TTM EBIT₹727.10 Cr
Last Qtr PAT₹165.49 Cr
Last Qtr EBITDA₹229.78 Cr
Last Qtr EBIT₹173.38 Cr
Profitability
ROE20.42%
ROCE18.87%
TTM NPM12.68%
TTM EBITDA %18.72%
Curr OPM13.03%
Last OPM9.71%
Curr NPM
Last NPM
Curr EPS₹17.02
Last EPS₹13.77
Balance sheet
Equity₹92.17 Cr
Reserve₹3.02K Cr
Total Debt₹1,761.69 Cr
D/E0.57x
Interest %24.51%
Curr Interest₹40.56 Cr
Price / range
Close₹1219.80
vs 52W High
vs 52W Low
MA50
MA200
Returns
1D+1.63%
1W+3.08%
1M+28.52%
3M+9.81%
6M+34.77%
1Y+39.22%
2Y-10.73%
3Y+151.17%
5Y+100.16%
Diwali+33.52%
Sector peers — Pharmaceuticals
CompanyCloseMkt CapTTM P/EROE
SUNPHARMA1837.30₹4.41L Cr36.4514.50%
DIVISLAB9375.00₹2.49L Cr85.0617.45%
TORNTPHARM4840.00₹1.84L Cr77.3225.70%
ZYDUSLIFE1160.00₹1.16L Cr25.8516.94%
CIPLA1394.50₹1.13L Cr33.419.75%
LAURUSLABS1954.00₹1.06L Cr96.4520.58%
AUROPHARMA1734.00₹99.77K Cr27.099.79%
DRREDDY1185.00₹98.91K Cr30.638.40%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Standalone

16 lines · 6 periods
MetricJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue582.65+16.9%605.74553.63522.15498.622,180.14
Other Income1.483.97103.2414.091.76123.06
Total Income584.12+16.7%609.71656.88536.24500.372,303.20
Interest28.5126.6627.2529.4130.45113.77
Expenditure-575.77-19.0%-583.20-522.07-510.86-483.97-2,100.10
PBDT000000
EBITDA61.12-9.1%74.3981.2162.2167.24285.05
Depreciation-25.73-25.19-22.40-21.51-22.14-91.24
EBIT35.39-21.5%49.2058.8140.7045.10193.81
PBT84.76+416.8%26.51134.8025.3916.40203.10
Tax-11.83-10.16-12.916.65-3.06-19.47
Equity92.1792.1792.17092.1692.17
OPM14.514.3520.524.863.288.82
Net Profit72.93+446.3%16.35121.9032.0413.35183.64
NPM12.492.6818.566.142.677.97
EPS7.91+445.5%1.7713.223.481.4519.92

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 6 years
MetricFY 25-26FY 24-25FY 23-24FY 22-23FY 21-22FY 20-21
Revenue2,180.14+1.9%2,139.42-0.6%2,153.26+16.1%1,854.50-6.3%1,979+6.5%1,857.57
Other Income123.0646.1972.3184.07123.4989
Total Income2,303.20+5.4%2,185.61-1.8%2,225.56+14.8%1,938.56-7.8%2,102.49+8.0%1,946.56
Expenditure-2,100.10+0.4%-2,107.50+2.0%-2,150.58-8.2%-1,988.32+4.5%-2,080.98-13.4%-1,834.93
Interest-113.77-145.91-167.93-138.68-74.24-65.34
PBDT000000
EBITDA285.05+8.6%262.44+2.8%255.28+159.2%98.48+28.5%76.63-59.1%187.32
Depreciation-91.24-84.61-84.67-93.62-104.37-99.34
EBIT193.81+9.0%177.83+4.2%170.61+3410.5%4.86+117.5%-27.74-131.5%87.98
PBT203.10+160.1%78.08+12.2%69.62+207.5%-64.76-401.1%21.51-80.7%111.64
Tax-19.47-18.93-4.1369.44158.68-33.40
Equity92.1792.160000
OPM (%)8.823.573.00-3.001.006.00
Net Profit183.64-93.6%2,886.21+4307.1%65.49+1299.4%4.68-97.4%180.19+130.3%78.24
NPM (%)7.97132.063.000.009.004.00
EPS (Rs)19.92-93.6%313.68+4256.7%7.20+1284.6%0.52-97.4%20.08+130.0%8.73
CEPS19.92313.657.190.5220.078.72

Consolidated

16 lines · 6 periods
MetricJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue1,265.41+13.0%1,323.471,194.651,220.831,119.744,858.68
Other Income4.898.13106.8627.148.58150.71
Total Income1,270.30+12.6%1,331.601,301.511,247.971,128.325,009.40
Interest40.5641.5843.3846.1347.46178.55
Expenditure-1,132.59-13.5%-1,178.59-1,052.70-1,085.03-998.01-4,314.34
PBDT000000
EBITDA229.78+5.4%239.71235.95231.57218.08925.29
Depreciation-56.40-53.25-50.62-49.64-48.89-202.40
EBIT173.38+2.5%186.46185.33181.93169.19722.89
PBT200.90+64.8%146.60245.51154.17121.94668.22
Tax-34.12-18.77-37.35-21.59-16.45-94.17
Equity92.1792.170092.1692.17
OPM15.8211.0118.8612.3510.8113.34
Net Profit165.49+56.7%129.28208.12131.52105.59574.52
NPM13.039.7115.9910.549.3611.47
EPS17.02+57.4%13.7721.9313.8410.8160.34

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 6 years
MetricFY 25-26FY 24-25FY 23-24FY 22-23FY 21-22FY 20-21
Revenue4,858.68+6.4%4,565.34+12.7%4,051.12+9.8%3,688.39+20.1%3,070.25-7.4%3,315.87
Other Income150.7158.7239.7090.33131.9951.43
Total Income5,009.40+8.3%4,624.06+13.0%4,090.83+8.3%3,778.72+18.0%3,202.24-4.9%3,367.30
Expenditure-4,314.34-2.6%-4,203.63-9.4%-3,842.99-2.1%-3,762.60-7.5%-3,500.11-15.2%-3,037.39
Interest-178.55-248.85-314.45-261.14-176.74-150.07
PBDT000000
EBITDA925.29+15.3%802.82+8.0%743.26+72.8%430.18+2239.1%-20.11-103.2%634.84
Depreciation-202.40-192.26-220.68-243.25-233.01-206.29
EBIT722.89+18.4%610.56+16.8%522.58+179.6%186.93+173.9%-253.12-159.1%428.55
PBT668.22+37.8%485.08+725.1%58.79+6490.2%-0.92+99.8%-541.70-245.1%373.26
Tax-94.17-77.52-31.5955.30178.26-31.65
Equity92.1792.160000
OPM (%)13.3410.491.44-0.02-16.9211.08
Net Profit574.52-84.0%3,597.51+3914.6%-94.31+55.6%-212.33+55.2%-474.25-284.0%257.73
NPM (%)11.4777.80-2.31-5.62-14.817.65
EPS (Rs)60.34-84.5%390.54+5132.7%-7.76+65.5%-22.49+56.1%-51.28-271.2%29.96
CEPS60.34390.50-7.77-22.49-51.2829.92

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

19
YearTypeAmountEx-Date
2026Final Dividend531 Jul 2026
2025Final Dividend422 Jul 2025
2024Final Dividend2.509 Sep 2024
2023Final Dividend1.504 Aug 2023
2021Final Dividend2.505 Aug 2021
2020Final Dividend224 Jul 2020
2020Interim Dividend1222 Aug 2019
2019Final Dividend319 Jul 2019
2018Final Dividend212 Sep 2018
2017Final Dividend4.507 Sep 2017
2016Final Dividend421 Jul 2016
2015Final Dividend322 Jul 2015
2015Special Dividend10516 Oct 2014
2014Final Dividend501 Sep 2014
2014Special Dividend50019 Dec 2013
2013Final Dividend230 May 2013
2012Final Dividend214 May 2012
2011Final Dividend1.518 May 2011
2010Final Dividend1.521 May 2010

Bonus

0

No bonus history.

Split

0

No split history.

Loading company dashboard...
Fetching ratios, charts, and peers